Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIO) Gross Margin (2022 - 2025)

Cardio Diagnostics Holdings' Gross Margin history spans 4 years, with the latest figure at 4348.94% for Q1 2025.

  • For Q1 2025, Gross Margin fell 423295.0% year-over-year to 4348.94%; the TTM value through Mar 2025 reached 853.99%, down 51946.0%, while the annual FY2024 figure was 422.92%, 40597.0% up from the prior year.
  • Gross Margin for Q1 2025 was 4348.94% at Cardio Diagnostics Holdings, down from 746.76% in the prior quarter.
  • Across five years, Gross Margin topped out at 115.98% in Q1 2024 and bottomed at 4348.94% in Q1 2025.
  • The 4-year median for Gross Margin is 715.22% (2023), against an average of 1331.08%.
  • The largest annual shift saw Gross Margin skyrocketed 204026bps in 2023 before it tumbled -423295bps in 2025.
  • A 4-year view of Gross Margin shows it stood at 2755.47% in 2022, then surged by 74bps to 715.22% in 2023, then decreased by -4bps to 746.76% in 2024, then plummeted by -482bps to 4348.94% in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Gross Margin are 4348.94% (Q1 2025), 746.76% (Q4 2024), and 691.17% (Q3 2024).